Hyosung Chemical Corporation: debt-to-equity, ROE and more
KOSPI, Legal name Hyosung Chemical Corporation
Latest figures are the FY2025 consolidated summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 309.8%
- Equity ratio
- 24.4%
- ROE
- 51.5%
- Op. margin
- -6.9%
- Rev. growth
- -17.5%
- Interest coverage
- n/a
Condition flags
- Latest operating profit is not above zero, or not reported.
- Operating loss for 4 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
No dividend data yet for this company.
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 consolidated | 509.5% | 16.4% | 14.0% | 6.1% | n/a |
| FY2022 consolidated | 2,631.8% | 3.7% | -356.7% | -11.7% | 17.3% |
| FY2023 consolidated | 4,934.6% | 2.0% | -560.6% | -6.8% | -3.0% |
| FY2024 consolidated | n/a | -2.1% | n/a | -6.0% | 1.7% |
| FY2025 consolidated | 309.8% | 24.4% | 51.5% | -6.9% | -17.5% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩2.45T | ₩2.88T | ₩2.79T | ₩2.84T | ₩2.34T |
| Operating profit | ₩148.6B | -₩336.7B | -₩188.8B | -₩170.5B | -₩160.5B |
| Pre-tax income | ₩114.4B | -₩448.3B | -₩371.9B | -₩361.2B | -₩336.9B |
| Net income | ₩70.4B | -₩408.9B | -₩346.9B | -₩325.7B | ₩326.0B |
| Total assets | ₩3.06T | ₩3.13T | ₩3.12T | ₩3.27T | ₩2.59T |
| Total liabilities | ₩2.55T | ₩3.02T | ₩3.05T | ₩3.34T | ₩1.96T |
| Total equity | ₩501.5B | ₩114.6B | ₩61.9B | -₩68.0B | ₩633.1B |
| Paid-in capital | ₩16.0B | ₩16.0B | ₩19.0B | ₩19.0B | ₩19.0B |
| Debt/equity (source value) | 509.5% | 2,631.8% | 4,934.6% | 100.0% | 309.8% |
Company outline (FSC)
- Market
- KOSPI
- Fiscal year end
- Dec
- Founded
- 2018-06-04
- Listed
- 18/07/13
- Employees
- 884
- Auditor
- 삼일회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1101116770188
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 효성화학Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.